These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 36810098)

  • 21. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
    Plaks V; Kong N; Werb Z
    Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bench to Bedside: New Therapeutic Approaches with Extracellular Vesicles and Engineered Biomaterials for Targeting Therapeutic Resistance of Cancer Stem Cells.
    Ingavle G; Das M
    ACS Biomater Sci Eng; 2022 Nov; 8(11):4673-4696. PubMed ID: 36194142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting hypoxia-induced tumor stemness by activating pathogen-induced stem cell niche defense.
    Bhuyan S; Pal B; Pathak L; Saikia PJ; Mitra S; Gayan S; Mokhtari RB; Li H; Ramana CV; Baishya D; Das B
    Front Immunol; 2022; 13():933329. PubMed ID: 36248858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The strategies to cure cancer patients by eradicating cancer stem-like cells.
    Mai Y; Su J; Yang C; Xia C; Fu L
    Mol Cancer; 2023 Oct; 22(1):171. PubMed ID: 37853413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophages and cancer stem cells: a malevolent alliance.
    Allavena P; Digifico E; Belgiovine C
    Mol Med; 2021 Sep; 27(1):121. PubMed ID: 34583655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Mechanisms of Tumor Cell Stemness Modulation during Formation of Spheroids.
    Ponomarev AS; Gilazieva ZE; Solovyova VV; Rizvanov AA
    Biochemistry (Mosc); 2023 Jul; 88(7):979-994. PubMed ID: 37751868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
    Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
    Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
    Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
    Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis.
    Nallasamy P; Nimmakayala RK; Parte S; Are AC; Batra SK; Ponnusamy MP
    Mol Cancer; 2022 Dec; 21(1):225. PubMed ID: 36550571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche.
    Kilmister EJ; Tan ST
    J Histochem Cytochem; 2021 Dec; 69(12):835-847. PubMed ID: 34165363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells.
    Relation T; Dominici M; Horwitz EM
    Stem Cells; 2017 May; 35(5):1123-1130. PubMed ID: 28207184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis.
    Singh D; Khan MA; Siddique HR
    Biochem Pharmacol; 2022 Apr; 198():114955. PubMed ID: 35181312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy.
    Taeb S; Ashrafizadeh M; Zarrabi A; Rezapoor S; Musa AE; Farhood B; Najafi M
    Curr Cancer Drug Targets; 2022; 22(1):18-30. PubMed ID: 34951575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis.
    Kapoor-Narula U; Lenka N
    Cytokine; 2022 Sep; 157():155968. PubMed ID: 35872504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA N
    Zhang Z; Zhang C; Luo Y; Zhang G; Wu P; Sun N; He J
    Clin Transl Med; 2021 Sep; 11(9):e525. PubMed ID: 34586737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reprograming immune microenvironment modulates CD47 cancer stem cells in hepatocellular carcinoma.
    Abd El-Fattah EE; Selim HM
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109475. PubMed ID: 36435064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
    Wu HJ; Chu PY
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer stem cell-immune cell collusion in immunotherapy.
    Wang YY; Wang WD; Sun ZJ
    Int J Cancer; 2023 Aug; 153(4):694-708. PubMed ID: 36602290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The key roles of cancer stem cell-derived extracellular vesicles.
    Su C; Zhang J; Yarden Y; Fu L
    Signal Transduct Target Ther; 2021 Mar; 6(1):109. PubMed ID: 33678805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer stem cells: Recent insights and therapies.
    Zhou H; Tan L; Liu B; Guan XY
    Biochem Pharmacol; 2023 Mar; 209():115441. PubMed ID: 36720355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.